C
Caris Life Sciences Inc
NASDAQ:CAI
Caris Life Sciences Inc
NASDAQ:CAI
Price:
18.47
USD
-3.15%
Market Closed
Market Cap:
$5.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
N
|
Nordic Iron Ore AB
STO:NIO
|
SE |
|
Fitzroy River Corporation Ltd
ASX:FZR
|
AU |
|
Sixt SE
XETRA:SIX2
|
DE |
|
K
|
Koh Brothers Group Ltd
SGX:K75
|
SG |
|
A
|
Aplab Ltd
BSE:517096
|
IN |
|
Angang Steel Co Ltd
SZSE:000898
|
CN |
|
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
|
CN |
|
Gemdale Properties and Investment Corporation Ltd
HKEX:535
|
HK |
|
Amsc ASA
OSE:AMSC
|
NO |
|
Merus NV
NASDAQ:MRUS
|
NL |
|
S
|
Shelter Infra Projects Ltd
BSE:526839
|
IN |
|
Plato Capital Ltd
SGX:YYN
|
MY |
|
Gama Aviation PLC
LSE:GMAA
|
UK |
|
Future Link Network Co Ltd
TSE:9241
|
JP |
|
N
|
NHN KCP Corp
KOSDAQ:060250
|
KR |
|
A
|
Atos SE
DUS:AXI
|
FR |
|
F
|
Fibocom Wireless Inc
SZSE:300638
|
CN |
|
Swelect Energy Systems Ltd
NSE:SWELECTES
|
IN |
|
SPC Samlip Co Ltd
KRX:005610
|
KR |
|
Reach Resources Ltd
ASX:RR1
|
AU |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
Income Statement
Earnings Waterfall
Caris Life Sciences Inc
Caris Life Sciences Inc
Income Statement
Caris Life Sciences Inc
Caris Life Sciences Inc
Currency:
| Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
32
|
45
|
0
|
|
| Revenue |
715
N/A
|
931
+30%
|
812
-13%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(363)
|
(433)
|
(271)
|
|
| Gross Profit |
351
N/A
|
499
+42%
|
541
+8%
|
|
| Operating Income | ||||
| Operating Expenses |
(684)
|
(799)
|
(496)
|
|
| Selling, General & Administrative |
(522)
|
(615)
|
(396)
|
|
| Research & Development |
(162)
|
(184)
|
(100)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
|
| Operating Income |
(333)
N/A
|
(300)
+10%
|
45
N/A
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(104)
|
(113)
|
(93)
|
|
| Non-Reccuring Items |
(18)
|
(18)
|
(20)
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(456)
N/A
|
(432)
+5%
|
(68)
+84%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
0
|
|
| Income from Continuing Operations |
(456)
|
(432)
|
(68)
|
|
| Net Income (Common) |
(1 022)
N/A
|
(998)
+2%
|
(538)
+46%
|
|
| EPS (Diluted) |
-3.63
N/A
|
-3.35
+8%
|
-3.22
+4%
|
|
Switch to:
Switch to:
See Also
Discover More
